Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age ...

The drugmaker has received the USFDA's final approval to manufacture a particular corticosteroid called Deflazacort to treat Duchenne muscular dystrophy.

As per the company’s filing, this new subsidiary will be the vehicle through which Zydus plans to acquire the equity shares of Amplitude Surgical SA.

Stocks like NCL Industries, Persistent Systems, Repco Home Finance, JK Cement, Canara Bank, Union Bank of India, and Yatra ...

Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, ...

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) tablets in four strengths - 6 mg, 18 mg, 30 mg, and 36 mg.

SAS has an authorised share capital of €1,000 and a paid-up share capital of €100. The subsidiary is currently an investment ...

Stocks including HCL Technologies, IRCON International, Zydus Lifesciences, Tata Power, Cyient, Indian Hotels, JK Cement, Havells and Macrotech Developers will be in the spotlight on Tuesday, April 15 ...

The NSE Nifty IT may rise in Tuesday's session as the US President Donald Trump granted exemption to certain electronic products and components. Track live updates about stock market here on April 15.

Sun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US ...

Acting on a complaint filed by pharmaceutical major Zydus Healthcare Limited, the Drugs Control Department of the Delhi government has seized counterfeit Thrombophob ointments worth ...

DCA Delhi seizes counterfeit version of topical medication, Thrombophob 20gm: Peethaambaran Kunnathoor, Chennai Tuesday, April 15, 2025, 08:00 Hrs [IST] In a major breakthrough in ...